FDA and Manufacturers Intensify Concerns about Data Integrity

被引：0
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2016年 / 29卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
[21]   Safety concerns at the FDA [J].
不详 .
LANCET, 2005, 365 (9461) :727-728
[22]   Pharmaceutical Data Integrity: issues, challenges and proposed solutions for manufacturers and inspectors [J].
Hock, Sia Chong ;
Tay, Vernon ;
Sachdeva, Vimal ;
Wah, Chan Lai .
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2020, 9 (04) :171-182
[23]   Combining efficiency and concerns about integrity when using human biobanks [J].
Hansson, Mats G. .
STUDIES IN HISTORY AND PHILOSOPHY OF SCIENCE PART C-STUDIES IN HISTORY AND PHILOSOPHY OF BIOLOGICAL AND BIOMEDIAL SCIENCES, 2006, 37 (03) :520-532
[24]   US FDA has concerns about safety of compounded ketamine nasal spray [J].
Reactions Weekly, 2022, 1895 (1) :3-3
[25]   FDA Releases Guidance on Biosimilars, Therapeutic Proteins, and Data Integrity [J].
不详 .
BIOPHARM INTERNATIONAL, 2016, 29 (05) :8-8
[26]   What's New with the FDA's Data Integrity Guidance? [J].
McDowall, R. D. .
SPECTROSCOPY, 2016, 31 (09) :22-29
[27]   Concerns about modelling of the EDGES data Reply [J].
Bowman, Judd D. ;
Rogers, Alan E. E. ;
Monsalve, Raul A. ;
Mozdzen, Thomas J. ;
Mahesh, Nivedita .
NATURE, 2018, 564 (7736) :E35-E35
[28]   MANUFACTURERS VIEW OF PRODUCT INTEGRITY [J].
GADSDEN, HW .
FOOD DRUG COSMETIC LAW JOURNAL, 1972, 27 (01) :34-39
[29]   Concerns about pathology expertise and data quality [J].
McInnes, Elizabeth F. ;
Meyerholz, David K. ;
Arends, Mark J. .
JOURNAL OF PATHOLOGY, 2023, 259 (04) :468-468
[30]   Opioid Regulation Challenges FDA and Manufacturers [J].
Wechsler, Jill .
BIOPHARM INTERNATIONAL, 2013, 26 (12) :12-13
12345